First-in-human phase 1/1b study to evaluate sitravatinib in patients with advanced solid tumors

Bauer, T., Cho, B. C., Heist, R., Bazhenova, L., Werner, T., Goel, S., Kim, D.-W., Adkins, D., Carvajal, R. D., Alva, A., Eaton, K., Wang, J., Liu, Y., Yan, X., Christensen, J., Neuteboom, S., Chao, R., & Pant, S. (2022). First-in-human phase 1/1b study to evaluate sitravatinib in patients with advanced solid tumors. Investigational New Drugs, 40(5), 990–1000. https://doi.org/10.1007/s10637-022-01274-y
Authors:
Todd Bauer
Byong Chul Cho
Rebecca Heist
Lyudmila Bazhenova
Theresa Werner
Sanjay Goel
Dong-Wan Kim
Douglas Adkins
Richard D. Carvajal
Ajjai Alva
Keith Eaton
Judy Wang
Yong Liu
Xiaohong Yan
Jamie Christensen
Saskia Neuteboom
Richard Chao
Shubham Pant
Affiliated Authors:
Richard D. Carvajal
Subjects:
Mechanisms of Apoptotic Cell Clearance and Immune Regulation (OpenAlex Topic)
Pancreatic Cancer Research and Treatment (OpenAlex Topic)
Renal Cell Carcinoma (OpenAlex Topic)
Anilides (MeSH)
Neoplasms (MeSH)
Pyridines (MeSH)
Author Keywords:
sitravatinib
advanced solid tumors
pharmacokinetics
adverse events
objective response rate
elink
Publication Type:
Article
Unique ID:
10.1007/s10637-022-01274-y
PMID:
35767205
DOI:
10.1007/s10637-022-01274-y
Journal:
Investigational New Drugs
Publication Date:
Data Source:
Scopus
Source Link:
View Scopus Record
View PubMed Record
View OpenAlex Record
View Web of Science Record

Record Created: